NaTure CHemisTry
Articles
11. Downey, A. M. & Hocek, M. Strategies toward protecting group-free
glycosylation through selective activation of the anomeric center.
Beilstein J. Org. Chem. 13, 1239–1279 (2017).
43. Jacobsson, M., Malmberg, J. & Ellervik, U. Aromatic O-glycosylation.
Carbohydr. Res. 341, 1266–1281 (2006).
44. Jensen, K. J. O-Glycosylations under neutral or basic conditions.
J. Chem. Soc., Perkin Trans. 1, 2219–2233 (2002).
12. Taylor, M. S. Catalyst-controlled, regioselective reactions of carbohydrate
derivatives. Top. Curr. Chem. 372, 125–155 (2016).
45. Park, Y. et al. Macrocyclic bis-thioureas catalyze stereospecifc glycosylation
reactions. Science 355, 162–166 (2017).
13. Lee, D. & Taylor, M. S. Catalyst-controlled regioselective reactions of
carbohydrate derivatives. Synthesis 44, 3421–3431 (2012).
46. Hahm, H. S. et al. Automated glycan assembly of complex oligosaccharides
related to blood group determinants. J. Org. Chem. 81, 5866–5877 (2016).
47. Mydock, L. K. & Demchenko, A. V. Mechanism of chemical O-glycosylation:
from early studies to recent discoveries. Org. Biomol. Chem. 8, 497–510 (2010).
48. Nicolaou, K. C. & Mitchell, H. J. Adventures in carbohydrate chemistry: new
synthetic technologies, chemical synthesis, molecular design, and chemical
biology. Angew. Chem. Int. Ed. 40, 1576–1624 (2001).
14. Wang, L.-X. & Amin, M. N. Chemical and chemoenzymatic
synthesis of glycoproteins for deciphering functions. Chem. Biol. 21,
51–66 (2014).
15. Nakayama, A. et al. Enzymatic glycosylation of vancomycin aglycon:
completion of a total synthesis of vancomycin and N- and C-terminus
substituent efects of the aglycon substrate. Org. Lett. 16, 3572–3575 (2014).
16. Li, T.-L., Liu, Y.-C. & Lyu, S.-Y. Combining biocatalysis and chemoselective
chemistries for glycopeptide antibiotics modifcation. Curr. Opin. Chem. Biol.
16, 170–178 (2012).
49. Toshima, K. Glycosyl fuorides in glycosidations. Carbohydr. Res. 327,
15–26 (2000).
50. Shimizu, M., Togo, H. & Yokoyama, M. Chemistry of glycosyl fuorides.
Synthesis 1998, 799–822 (1998).
51. Willems, L. I. et al. From covalent glycosidase inhibitors to activity-based
glycosidase probes. Chem. Eur. J. 20, 10864–10872 (2014).
52. Rempel, B. P. & Withers, S. G. Covalent inhibitors of glycosidases and their
applications in biochemistry and biology. Glycobiology 18, 570–586 (2008).
53. Evans, M. J. & Cravatt, B. F. Mechanism-based profling of enzyme families.
Chem. Rev. 106, 3279–3301 (2006).
54. Banait, N. S. & Jencks, W. P. Reactions of anionic nucleophiles with
α-d-glucopyranosyl fuoride in aqueous solution through a concerted, ANDN
(SN2) mechanism. J. Am. Chem. Soc. 113, 7951–7958 (1991).
55. Banait, N. S. & Jencks, W. P. General-acid and general-base catalysis of the
cleavage of α-d-glucopyranosyl fuoride. J. Am. Chem. Soc. 113, 7958–7963 (1991).
56. Pelletier, G., Zwicker, A., Allen, C. L., Schepartz, A. & Miller, S. J. Aqueous
glycosylation of unprotected sucrose employing glycosyl fuorides in the
presence of calcium ion and trimethylamine. J. Am. Chem. Soc. 138,
3175–3182 (2016).
57. Bohé, L. & Crich, D. A propos of glycosyl cations and the mechanism of
chemical glycosylation; the current state of the art. Carbohydr. Res. 403,
48–59 (2015).
58. Chan, J., Sannikova, N., Tang, A. & Bennet, A. J. Transition-state structure
for the quintessential SN2 reaction of a carbohydrate: reaction of α
-glucopyranosyl fuoride with azide ion in water. J. Am. Chem. Soc. 136,
12225–12228 (2014).
17. Zhang, C. et al. Exploiting the reversibility of natural product
glycosyltransferase-catalyzed reactions. Science 313, 1291–1294 (2006).
18. Demchenko, A. V. Handbook of Chemical Glycosylation: Advances in
Stereoselectivity and Terapeutic Relevance (Wiley-VCH, Weinheim, 2008).
19. deGruyter, J. N., Malins, L. R. & Baran, P. S. Residue-specifc peptide
modifcation: a chemist's guide. Biochemistry 56, 3863–3873 (2017).
20. Gunnoo, S. B. & Madder, A. Bioconjugation—using selective chemistry to
enhance the properties of proteins and peptides as therapeutics and carriers.
Org. Biomol. Chem. 14, 8002–8013 (2016).
21. Koniev, O. & Wagner, A. Developments and recent advancements in the feld
of endogenous amino acid selective bond forming reactions for bioconjugation.
Chem. Soc. Rev. 44, 5495–5551 (2015).
22. Boutureira, O. & Bernardes, G. J. L. Advances in chemical protein
modifcation. Chem. Rev. 115, 2174–2195 (2015).
23. Gamblin, D. P., Scanlan, E. M. & Davis, B. G. Glycoprotein synthesis: an
update. Chem. Rev. 109, 131–163 (2009).
24. Davis, B. G. Synthesis of glycoproteins. Chem. Rev. 102, 579–602 (2002).
25. Lamandé-Langle, S. et al. ‘Click’ glycosylation of peptides through cysteine
propargylation and CuAAC. Bioorg. Med. Chem. 22, 6672–6683 (2014).
26. Dondoni, A. & Marra, A. Recent applications of thiol-ene coupling as a click
process for glycoconjugation. Chem. Soc. Rev. 41, 573–586 (2012).
27. Fernandez-Gonzalez, M. et al. Site-selective chemoenzymatic construction
of synthetic glycoproteins using endoglycosidases. Chem. Sci. 1,
709–715 (2010).
59. Stubbs, J. M. & Marx, D. Glycosidic bond formation in aqueous solution: on
the oxocarbenium intermediate. J. Am. Chem. Soc. 125, 10960–10962 (2003).
60. Micheel, F. & Klemer, A. Über den Reaktionsmechanismus der
Glycosidbildung aus α- und β-1-Fluor-Derivaten der d-Glucose und
d-Mannose. Chem. Ber. 91, 663–667 (1958).
28. Bernardes, G. J. L. et al. From disulfde- to thioether-linked glycoproteins.
Angew. Chem. Int. Ed. 47, 2244–2247 (2008).
29. Krauss, I. J. et al. Fully synthetic carbohydrate HIV antigens designed on the
logic of the 2G12 antibody. J. Am. Chem. Soc. 129, 11042–11044 (2007).
30. Mu, J. & Roach, P. J. Characterization of human glycogenin-2, a self-
glucosylating initiator of liver glycogen metabolism. J. Biol. Chem. 273,
34850–34856 (1998).
31. Zarschler, K. et al. Protein tyrosine O-glycosylation—a rather unexplored
prokaryotic glycosylation system. Glycobiology 20, 787–798 (2010).
32. Halim, A. et al. Site-specifc characterization of threonine, serine, and tyrosine
glycosylations of amyloid precursor protein/amyloid β-peptides in human
cerebrospinal fuid. Proc. Natl Acad. Sci. USA 108, 11848–11853 (2011).
33. Lafte, P. & Daniellou, R. Rare and unusual glycosylation of peptides and
proteins. Nat. Prod. Rep. 29, 729–738 (2012).
34. Wang, P., Nilsson, J., Brinkmalm, G., Larson, G. & Huang, X. Synthesis aided
structural determination of amyloid-β(1–15) glycopeptides, new biomarkers
for Alzheimer's disease. Chem. Commun. 50, 15067–15070 (2014).
35. Fichna, J. et al. Novel glycosylated endomorphin-2 analog produces potent
centrally-mediated antinociception in mice afer peripheral administration.
Bioorg. Med. Chem. Lett. 23, 6673–6676 (2013).
61. Halcomb, R. L. & Danishefsky, S. J. On the direct epoxidation of glycals:
application of a reiterative strategy for the synthesis of β-linked
oligosaccharides. J. Am. Chem. Soc. 111, 6661–6666 (1989).
62. Underwood, C. R. et al. Crystal structure of glucagon-like peptide-1 in
complex with the extracellular domain of the glucagon-like peptide-1
receptor. J. Biol. Chem. 285, 723–730 (2010).
63. Kiefer, T. J. & Habener, J. F. Te glucagon-like peptides. Endocrin. Rev. 20,
876–913 (1999).
64. Zadina, J. E. et al. Endomorphins: novel endogenous μ-opiate receptor
agonists in regions of high μ-opiate receptor density. Ann. NY Acad. Sci. 897,
136–144 (1999).
65. Podlogar, B. L. et al. Conformational analysis of the endogenous μ-opioid
agonist endomorphin-1 using NMR spectroscopy and molecular modeling.
FEBS Lett. 439, 13–20 (1998).
66. Noda, M. et al. Isolation and structural organization of the human
preproenkephalin gene. Nature 297, 431–434 (1982).
36. Jansson, A. M. et al. Solid-phase glycopeptide synthesis of tyrosine-
glycosylated glycogenin fragments as substrates for glucosylation by
glycogenin. J. Chem. Soc., Perkin Trans. 1, 1001–1006 (1996).
37. Fahmi, N. E., Dedkova, L., Wang, B., Golovine, S. & Hecht, S. M. Site-specifc
incorporation of glycosylated serine and tyrosine derivatives into proteins.
J. Am. Chem. Soc. 129, 3586–3597 (2007).
67. Burgus, R. et al. Primary structure of the ovine hypothalamic luteinizing
hormone-releasing factor (LRF). Proc. Natl Acad. Sci. USA 69,
278–282 (1972).
68. Donaldson, Z. R. & Young, L. J. Oxytocin, vasopressin, and the neurogenetics
of sociality. Science 322, 900–904 (2008).
69. Austin, L. A. & Heath, H. 3rd Calcitonin physiology and pathophysiology.
N. Engl. J. Med. 304, 269–278 (1981).
38. Michael, A. On the synthesis of helicon and phenolglucoside. Am. Chem. J. 1,
305–312 (1879).
39. Brito-Arias, M. Synthesis and Characterization of Glycosides 81–168
(Springer International, Cham, 2016).
40. Capicciotti, C. J. et al. O-Aryl-glycoside ice recrystallization inhibitors as novel
cryoprotectants: a structure–function study. ACS Omega 1,
Carbohydr. Res. 403, 13–22 (2015).
656–662 (2016).
72. Brimble, M. A. et al. Synthesis of the antimicrobial S-linked glycopeptide,
glycocin F. Chem. Eur. J. 21, 3556–3561 (2015).
41. Henderson, A. S., Medina, S., Bower, J. F. & Galan, M. C. Nucleophilic
aromatic substitution (SNAr) as an approach to challenging carbohydrate–aryl
ethers. Org. Lett. 17, 4846–4849 (2015).
73. Rojas-Ocáriz, V. et al. Design of α-S-neoglycopeptides derived from MUC1
with a fexible and solvent-exposed sugar moiety. J. Org. Chem. 81,
5929–5941 (2016).
42. Li, Y., Mo, H., Lian, G. & Yu, B. Revisit of the phenol O-glycosylation with
glycosyl imidates, BF3·OEt2 is a better catalyst than TMSOTf. Carbohydr. Res.
363, 14–22 (2012).
74. Kahne, D., Walker, S., Cheng, Y. & Van Engen, D. Glycosylation of unreactive
substrates. J. Am. Chem. Soc. 111, 6881–6882 (1989).
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.